Chi-Med Highlights Oral Presentations at 2019 ESMO Asia Annual Meeting

NEXT STORY
BeiGene Announces Clinical Data on Tislelizumab Presented at European Society for Medical Oncology (ESMO) Asia 2019 Congress
PREV STORY
Agios Presents New Pharmacodynamic and Response Data from Both Cohorts of the Perioperative Study of Vorasidenib and TIBSOVO® (ivosidenib) in Patients with IDH1 Mutant Positive Low-Grade Glioma
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Rexahn to Present Clinical Data at 2018 American Society of Clinical Oncology (ASCO) Annual Meeting

author_avatar
NASDAQ Market News

Novan Reports Full Year 2020 Financial Results and Provides Corporate Update

author_avatar
NASDAQ Market News

Santhera Announces Completion of First 6-Month Period of Pivotal VISION-DMD Trial with Vamorolone in Duchenne Muscular Dystrophy

author_avatar
NASDAQ Market News